Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
Malignant melanoma is the fastest-growing and 7th most ... Melanomas thicker than 1 mm may require up to four annual visits during the first 2 years, followed by biannual and annual exams.
As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
A 38-year-old British woman has been battling aggressive Stage 4 terminal melanoma—skin cancer—for the past eight years, ...
Learn how melanoma impacts African Americans, highlighting detection challenges, survival disparities, and prevention ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Melanoma is deadlier for Black individuals due to late diagnoses and hidden symptoms. Understanding the risks can save lives.
Ph.D. candidate in Georgetown University’s tumor biology program defended his dissertation, titled “Molecular Signatures of ...
23h
News Medical on MSNInhibiting S6K2 gene offers potential treatment for drug-resistant melanomaThe lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results